Asimov · 9 hours ago
Business Development Associate
Maximize your interview chances
Artificial Intelligence (AI)Biotechnology
Insider Connection @Asimov
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Drive revenue growth: Actively source and secure business opportunities with biopharma companies of varying sizes, ranging from virtual to top pharmas. Your goal is to drive significant revenue growth through these engagements.
Manage customer relationships: Play a key role in nurturing and maintaining relationships with clients throughout the entire partnership lifecycle, ensuring ongoing satisfaction and engagement.
Communicate value proposition: Effectively convey the technical and commercial benefits of our offerings to potential clients.
Structure deals: Work closely with the broader commercial team to develop deal structures that maximize value for all parties involved, both within our organization and for our external stakeholders.
Engage with industry: Represent the company at industry conferences, both through attendance and exhibition, to network and promote our services.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
At least 3 years of experience in a business development or sales role, specifically within the B2B biopharmaceutical tools sector.
A deep understanding of the therapeutics biomanufacturing landscape.
A robust and expanding network within the biopharma services and tools market.
Proven track record of managing long-term relationships with clients.
Knowledge of cell line development and upstream process development for biologics and/or viral vectors.
Preferred
An MBA or Master's degree is preferred.
Alternatively, a Bachelor's degree in Life Sciences coupled with relevant experience will be considered.
Company
Asimov
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Funding
Current Stage
Growth StageTotal Funding
$205MKey Investors
CPP InvestmentsHorizons VenturesAndreessen Horowitz
2023-01-05Series B· $175M
2020-01-01Series A· $25M
2017-12-19Seed· $5M
Recent News
GlobeNewswire News Room
2024-12-12
Company data provided by crunchbase